A detailed history of First Affirmative Financial Network transactions in Takeda Pharmaceutical CO LTD stock. As of the latest transaction made, First Affirmative Financial Network holds 41,852 shares of TAK stock, worth $598,065. This represents 0.3% of its overall portfolio holdings.

Number of Shares
41,852
Previous 35,827 16.82%
Holding current value
$598,065
Previous $553,000 10.67%
% of portfolio
0.3%
Previous 0.3%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Nov 20, 2025

BUY
$13.6 - $15.52 $81,940 - $93,508
6,025 Added 16.82%
41,852 $612,000
Q2 2025

Nov 20, 2025

BUY
$13.71 - $15.46 $109,145 - $123,077
7,961 Added 28.57%
35,827 $553,000
Q1 2025

Apr 11, 2025

BUY
$12.89 - $15.19 $93,632 - $110,340
7,264 Added 35.26%
27,866 $414,000
Q4 2024

Jan 23, 2025

BUY
$13.01 - $14.43 $61,615 - $68,340
4,736 Added 29.85%
20,602 $272,000
Q3 2024

Oct 10, 2024

BUY
$13.0 - $15.08 $206,258 - $239,259
15,866 New
15,866 $225,000

Others Institutions Holding TAK

About TAKEDA PHARMACEUTICAL CO LTD


  • Ticker TAK
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 3,109,050,112
  • Market Cap $44.4B
  • Description
  • Takeda Pharmaceutical Company Limited engages in the research, development, manufacture, marketing, and out-licensing of pharmaceutical products in Japan, the United States, Europe, Canada, Latin America, Russia, rest of Asia, and internationally. It offers pharmaceutical products in the areas of gastroenterology, rare diseases, plasma derived t...
More about TAK
Track This Portfolio

Track First Affirmative Financial Network Portfolio

Follow First Affirmative Financial Network and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of First Affirmative Financial Network, based on Form 13F filings with the SEC.

News

Stay updated on First Affirmative Financial Network with notifications on news.